Of course people would accept a TO with a 350% premium. You may have more luck finding a leprechaun at the end of a rainbow though.
Fair value remains between $0.175 and $0.19
- Forums
- ASX - By Stock
- EYE
- CMS Proposes Major Increase in Reimbursement for Canaloplasty
CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-463
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
|
|||||
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.39M |
Open | High | Low | Value | Volume |
22.5¢ | 22.5¢ | 22.0¢ | $20.50K | 93.21K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 82585 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.0¢ | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 61585 | 0.215 |
9 | 390311 | 0.210 |
5 | 113536 | 0.205 |
14 | 180879 | 0.200 |
2 | 20000 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.220 | 20000 | 1 |
0.225 | 48115 | 3 |
0.235 | 5645 | 1 |
0.240 | 50000 | 1 |
0.250 | 200000 | 3 |
Last trade - 11.17am 13/08/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online